Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma-Reference-Cited by-同舟云学术

Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma

Published:2017-08-10 Issue:9 Volume:6 Page:2164-2176
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Liapis Vasilios¹,Zysk Aneta¹,DeNichilo Mark²,Zinonos Irene¹,Hay Shelley¹,Panagopoulos Vasilios¹,Shoubridge Alexandra¹,Difelice Christopher¹,Ponomarev Vladimir³,Ingman Wendy⁴⁵,Atkins Gerald J.⁶,Findlay David M.⁶,Zannettino Andrew C. W.⁷,Evdokiou Andreas¹^ORCID

Affiliation:

1. Discipline of Surgery; Breast Cancer Research Unit; Basil Hetzel Institute and Centre for Personalised Cancer Medicine; University of Adelaide; Woodville South Australia Australia

2. Vascular Biology and Cell Trafficking Laboratory; Centre for Cancer Biology; University of South Australia; Adelaide South Australia Australia

3. Department of Radiology; Memorial Sloan-Kettering Cancer Center; New York New York

4. Discipline of Surgery; School of Medicine at The Queen Elizabeth Hospital; University of Adelaide; Woodville Australia

5. Robinson Research Institute; University of Adelaide; Adelaide Australia

6. Discipline of Orthopaedics and Trauma; University of Adelaide; Adelaide South Australia Australia

7. School of Medical Sciences; Myeloma Research Laboratory Cancer Theme; South Australian Health and Medical Research Institute (SAHMRI); Faculty of Health Science; University of Adelaide; Adelaide Australia

Funder

National Health and Medical Research Council

Hospital Research Foundation

National Breast Cancer Foundation

Breast Cancer Research Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference43 articles.

1. Bone and Soft Tissue Tumors

2. Osteosarcoma development and stem cell differentiation;Tang;Clin. Orthop. Relat. Res.,2008

3. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study;Link;Clin. Orthop. Relat. Res.,1991

4. Chemotherapy for osteosarcoma and Ewing's sarcoma;Saeter;Acta Orthop. Scand.,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-inducible factor (HIF)–mediated effects of the hypoxic niche in bone cancer;Bone Cancer;2022

2. Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy;Frontiers in Oncology;2021-07-29

3. The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy;Frontiers in Pharmacology;2021-04-19

4. Pharmacological interventions targeting bone diseases in adjunction with bone grafting;Dental Implants and Bone Grafts;2020

5. Prodrugs as drug delivery system in oncology;Cancer Chemotherapy and Pharmacology;2019-08-07